| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/07/2022 | 10.84% | HC Wainwright & Co. | $164 → $152 | Maintains | Buy |
| 08/22/2022 | 19.59% | HC Wainwright & Co. | $152 → $164 | Maintains | Buy |
| 05/02/2022 | 10.84% | HC Wainwright & Co. | $155 → $152 | Maintains | Buy |
| 03/08/2022 | 13.03% | HC Wainwright & Co. | $170 → $155 | Maintains | Buy |
| 02/22/2022 | 27.62% | Sidoti & Co. | → $175 | Upgrades | Neutral → Buy |
| 01/10/2022 | 23.97% | HC Wainwright & Co. | $160 → $170 | Maintains | Buy |
| 11/29/2021 | 27.62% | Sidoti & Co. | → $175 | Downgrades | Buy → Neutral |
| 08/02/2021 | 5.74% | Stephens & Co. | $140 → $145 | Downgrades | Overweight → Equal-Weight |
| 08/02/2021 | 16.68% | HC Wainwright & Co. | $145 → $160 | Upgrades | → Buy |
| 02/22/2021 | 2.09% | Stephens & Co. | $100 → $140 | Upgrades | Equal-Weight → Overweight |
| 02/22/2021 | 5.74% | HC Wainwright & Co. | $126 → $145 | Maintains | Buy |
| 08/04/2020 | -8.12% | HC Wainwright & Co. | $104 → $126 | Maintains | Buy |
| 07/10/2020 | -27.08% | Stephens & Co. | → $100 | Initiates Coverage On | → Equal-Weight |
| 05/04/2020 | -24.16% | HC Wainwright & Co. | $116 → $104 | Maintains | Buy |
| 02/24/2020 | -15.41% | HC Wainwright & Co. | $122 → $116 | Maintains | Buy |
| 05/06/2019 | -27.08% | Pivotal Research | → $100 | Downgrades | Buy → Hold |
| 10/16/2018 | -7.39% | Sidoti & Co. | $127 → $127 | Upgrades | Neutral → Buy |
| 09/25/2018 | 2.09% | HC Wainwright & Co. | → $140 | Initiates Coverage On | → Buy |
| 05/07/2018 | — | Pivotal Research | Upgrades | Sell → Hold | |
| 05/07/2018 | — | Vertical Research | Downgrades | Buy → Hold |
Balchem Questions & Answers
The latest price target for Balchem (NASDAQ: BCPC) was reported by HC Wainwright & Co. on November 7, 2022. The analyst firm set a price target for $152.00 expecting BCPC to rise to within 12 months (a possible 10.84% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Balchem (NASDAQ: BCPC) was provided by HC Wainwright & Co., and Balchem maintained their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Balchem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Balchem was filed on November 7, 2022 so you should expect the next rating to be made available sometime around November 7, 2023.
While ratings are subjective and will change, the latest Balchem (BCPC) rating was a maintained with a price target of $164.00 to $152.00. The current price Balchem (BCPC) is trading at is $137.13, which is out of the analyst's predicted range.